12 Health Care Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Bellicum Pharmaceuticals BLCM stock rose 135.4% to $0.94 during Monday's pre-market session. The market value of their outstanding shares is at $8.5 million.
  • Immuron IMRN stock increased by 62.56% to $3.04. The company's market cap stands at $17.3 million.
  • Trevena TRVN stock moved upwards by 24.88% to $0.79. The market value of their outstanding shares is at $7.0 million.
  • SenesTech SNES stock increased by 24.61% to $1.62. The company's market cap stands at $4.8 million.
  • ANI Pharmaceuticals ANIP shares moved upwards by 23.91% to $48.5. The market value of their outstanding shares is at $868.9 million. The company's, Q1 earnings came out today.
  • Sight Sciences SGHT shares increased by 10.0% to $11.0. The market value of their outstanding shares is at $532.9 million. As per the news, the Q1 earnings report came out 2 days ago.

Losers

  • Catalent CTLT shares decreased by 21.3% to $37.6 during Monday's pre-market session. The market value of their outstanding shares is at $6.7 billion.
  • Aptorum Gr APM shares decreased by 19.63% to $4.3. The company's market cap stands at $15.3 million.
  • Journey Medical DERM stock fell 12.26% to $1.36. The company's market cap stands at $24.3 million.
  • Vyant Bio VYNT shares decreased by 9.84% to $0.27. The company's market cap stands at $1.6 million.
  • BioXcel Therapeutics BTAI stock declined by 8.9% to $21.11. The company's market cap stands at $612.3 million. As per the press release, Q1 earnings came out today.
  • Aditxt ADTX stock declined by 8.33% to $0.61. The company's market cap stands at $3.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...